Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Drug Targets|January 4, 2021
An Insight Into Mitochondrial Dysfunction and its Implications in Neurological DiseasesRashid Waseem, Anas Shamsi, Syed N Kazim, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|February 26, 2024
Mycobacterium tuberculosis protein PPE15 (Rv1039c) possesses eukaryote-like SH3 domain that interferes with NADPH Oxidase assembly and Reactive Oxygen Species productionPriyanka, Sadhna Sharma, Hemant Joshi, et al.
Ageing Research Reviews|November 2, 2023
Recent advancement in therapeutic strategies for Alzheimer's disease: Insights from clinical trialsTanzeel Khan, Rashid Waseem, Mohammad Shahid, et al.
ACS Omega|March 18, 2024
Understanding the Modulation of α-Synuclein Fibrillation by N-Acetyl Aspartate: A Brain MetaboliteTanzeel Khan, Rashid Waseem, Mohammad Shahid, et al.
International Journal of Molecular Sciences|June 10, 2022
Unraveling the Binding Mechanism of Alzheimer's Drugs with Irisin: Spectroscopic, Calorimetric, and Computational ApproachesRashid Waseem, Anas Shamsi, Tanzeel Khan, et al.
International Journal of Biological Macromolecules|June 19, 2023
Inhibitory potential of N-acetylaspartate against protein glycation, AGEs formation and aggregation: Implication of brain osmolyte in glycation-related complicationsRashid Waseem, Tanzeel Khan, Anas Shamsi, et al.
Pharmaceutics|December 23, 2022
Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug Delivery ApproachesTanzeel Khan, Rashid Waseem, Zainy Zehra, et al.
Journal of Cellular Biochemistry|December 11, 2022
Characterization of advanced glycation end products and aggregates of irisin: Multispectroscopic and microscopic approachesRashid Waseem, Anas Shamsi, Tanzeel Khan, et al.
Pageof 2